Submission of Annual Report for the FY 2024-25
Reg. 34 (1) Annual Report.
Filed with BSE ·
6ix hasn’t read this filing yet.
View original source (BSE India)Vista Pharmaceuticals Ltd. on 6ix
Earlier from Vista Pharmaceuticals
- 34Th Annual General Meeting Of Vista Pharmaceuticals Limited On Tuesday, 30Th September 2025
- Vista Pharmaceuticals Ltd. Press Release Aug 13 2025
- Re-Appointment Of Mr. Murali Meraga (DIN: 02537507) As An Managing Director Of The Company
- Re-Appointment Of Mr. Pavan Sathvik Gilaka (DIN: 09733182) As An Whole Time Director Of The Company
- Re-Appointment Of Mr. Dhananjaya Alli (DIN: 00610909) As An Whole Time Director Of The Company
Later from Vista Pharmaceuticals
- Intimation Of Book Closure Regarding 34" Annual General Meeting
- Vista Pharmaceuticals Ltd. Press Release Sep 08 2025
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Vista Pharmaceuticals Ltd. Press Release Sep 09 2025
- Closure of Trading Window
Follow Vista Pharmaceuticals into a list and get an email when it puts out news.
Follow Vista Pharmaceuticals